← SynDRA
PARSACLISIB
SynDRA canonical compound SYN0039709 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | PIK3CD |
| Mechanism of action | PI3K inhibitor |
All known targets
Mechanisms of action (all sources)
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PI3K inhibitor
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- INCB050465
- INCB-050465
- Parsaclisib free base
- UNII-OS7097575K
- 1426698-88-5 (free base)
- OS7097575K
- (4R)-4-{3-[(1S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl}pyrrolidin-2-one
- (4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
- Parsaclisib [INN]
- Parsaclisib [USAN]
- Parsaclisib (USAN/INN)
- Parsaclisib [USAN:INN]
- INCB050465 free base
- INCB-050465 free base
- CHEMBL4297615
- SCHEMBL14736228
- BDBM272573
- EX-A2638
- WHO 10589
- DB14867
- US10065963, 32c
- HY-109068
- CS-0033435
- D11437
- (R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
- 2-Pyrrolidinone, 4-(3-((1S)-1-(4-amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4R)-
- IBI376
- parsaclisibum
- INCB50465
- RefChem:858696
- INCB-50465
- C20H22ClFN6O2
- Parsaclisib?
- PARSACLISIB [WHO-DD]
- orb1309280
- SCHEMBL30089288
- ZQPDJCIXJHUERQ-QWRGUYRKSA-N
- MFCD31692358
- AKOS040733972
Look up PARSACLISIB in the interactive SynDRA portal →